
Impact of Epstein-Barr virus infection on inflammatory bowel disease (IBD) clinical outcomes
Author(s) -
Andrea Núñez Ortiz,
M. Feria,
María Dolores de la Cruz Ramírez,
Lourdes Gómez Izquierdo,
Claudio Trigo Salado,
José Manuel Herrera Justiniano,
Eduardo Leo Carnerero
Publication year - 2021
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2021.7915/2021
Subject(s) - medicine , inflammatory bowel disease , lymphoma , gastroenterology , epstein–barr virus infection , ulcerative colitis , epstein–barr virus , lymphoproliferative disorders , crohn's disease , virus , disease , immunology
to evaluate the role of Epstein-Barr virus (EBV) on the intestinal mucosa in the evolution of inflammatory bowel disease (IBD). The risk factors for EBV infection and the frequency of EBV-associated lymphoproliferative disorders in IBD patients were also investigated.